Endothelial metaplasia in the iridocorneal endothelial syndrome

Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1896-901.

Abstract

Purpose: To test the hypothesis that the aberrant, cytokeratin-expressing cells that replace endothelium in the iridocorneal endothelial (ICE) syndrome are of endothelial origin.

Methods: Corneas from four patients with Chandler's syndrome and three with essential iris atrophy were examined by two-color immunofluorescence for simultaneous expression of cytokeratins and two markers of endothelial lineage: vimentin and the antigen recognized by the antiendothelial monoclonal antibody 2B4.14.1.

Results: In six corneas, unequivocal endothelial staining for cytokeratins was present; in each of these, cells coexpressing cytokeratins and the two endothelial markers were clearly identifiable. In the remaining cornea, weak cytokeratin staining that colocalized with vimentin was present.

Conclusions: These results lend strong support to the hypothesis that the "epithelial-like" endothelial cells in ICE syndrome are cells of endothelial lineage rather than heterotopia of epithelial cells; these cells probably arise via a metaplastic transformation of preexisting endothelium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal
  • Corneal Diseases / metabolism
  • Corneal Diseases / pathology*
  • Endothelium, Corneal / metabolism
  • Endothelium, Corneal / pathology*
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Iris Diseases / metabolism
  • Iris Diseases / pathology*
  • Keratins / metabolism
  • Metaplasia
  • Middle Aged
  • Syndrome
  • Vimentin / metabolism

Substances

  • Antibodies, Monoclonal
  • Vimentin
  • Keratins